View Article

Abstract

Three dimensional (3D) printing has been commonly used in areas such as aviation and automotive manufacturing. However, there has been increasing interest in the healthcare sector, specifically pharmaceuticals. Recently, the pharmaceutical industry have looked into how 3D printing can revolutionize drug manufacturing to give more accurate, personalized formulations. [1, 9, 15] The key advantage of using 3D printing over traditional manufacturing is the ability to tailor the drug to the individual patient. Traditional manufacturing is usually one size fits all and provides set standard dosages. Using 3D printing, drugs with specific dosages for the individual can be manufactured, increasing the efficiency of treatment and reducing negative side effects. Patients who require highly specific dosing, such as children and the elderly will benefit greatly. [11, 20] With increasing interest in 3D printing, much research has been conducted. Many different printing methods can be used to produce complex drug designs, controlled release drugs and combination drugs that would be difficult to achieve with traditional methods. As technology continues to improve, it is likely to have a huge impact on pharmaceutical science, providing patient-specific drugs. This review outlines the main 3D printing methods that are suitable for pharmaceutical manufacture. We also consider how these can help improve drug manufacture, patient outcomes and increase innovation in personalised medicine. [9, 10, 15, 21].

Keywords

Additive Manufacturing, Layer by layer fabrication, Rapid prototyping, Computer aided design (CAD), Digital Manufacturing, Customization, Smart manufacturing

Introduction

× Popup Image

Personalised medicine has become an area of increasing interest within both healthcare and the pharmaceutical industry. It involves designing treatment specific to the individual based on the understanding that every patient will respond differently to therapeutics due to individual and biological factors. [4, 14]

Medications have largely been produced in bulk using traditional methods for over two hundred years. There are only a few set strengths available meaning treatment lacks individuality for many individuals. Patients might not get the amount of medicine they need. This can lead to results or harmful side effects. It is said that many, as 70% of patients do not get the effect they should from regular medicines. Also 90% of medicines only work for 30 to 50% of people.Adverse drug reactions caused by poor interactions between drugs and a patients’ biology, contribute to approximately 7% of hospital admissions. This shows there is a clear need for more personalized and accurate treatments. [1, 4, 7, 14].Therefore personalisation is being developed where medication can be tailored to suit the patient based on their physical characteristics, current conditions, treatments, response to medication, genetic profile and demographic factors such as sex, age and weight. [1, 4, 14].

3D printing (additive manufacturing) has been found to be some of the most promising ways to achieve this. This involves creating items by building them up in layers using digital designs. This can be used within pharmacy to create 3D printed items known as printlets. These are small tablets which can be personalised to suit the needs of the patient.The dose, the way it is made and how it releases in the body can be changed for each person. Other parts that are not related to treatment, like the shape, the size, the feel and the taste can be changed to make the medicine more comfortable and easier to take for patients, kids and older people. [11 20].

Many studies have demonstrated the versatility of 3D printing technology with various dosage forms, including fast dissolving or dispersible tablets, sustained release tablets, gastric retention systems, suppositories, Minitablets and even medical devices. The polyprintlet has been developed whereby multiple drugs can be printed into one dose, allowing individualised dosing for patients on complex regimes. [22, 23, 24, 26]

3D printing allows for on demand manufacturing meaning bespoke medicines can be produced by hospitals and pharmacies. This increases availability of individualised medicines and reduces reliance on slow extemporaneous manufacture. It can also help reduce the length of a patients stay in hospital as the medicines will be manufactured in a more efficient manner. [9, 15]

This review will discuss the key 3D printing technologies used within pharmaceutical manufacturing, including fused deposition modelling (FDM), ink jet printing and stereolithography (SLA). Reasons for why 3D printing is being adopted, recent developments and applications will also be discussed, alongside challenges faced to fully introduce this technology into clinical and industrial pharmacy. Overall this review will highlight the role pharmacists, clinicians and biomedical engineers will have to aid innovation and implement 3D printing to develop safe, effective patient centred solutions to support the future of precision medicine. [9, 10, 15, 21]

HISTORY AND DEVELOPMENT OF 3D PRINTING:-

3D printing was created in the 1970s. Now it has evolved to become a powerful technology used in many fields such as manufacturing, healthcare and pharmacy. Below are the main points of its development. [9, 10, 15, 21] .

1971 Pierre A.L. Ciraud:-

In 1971 Pierre A.L. Ciraud presented a theory whereby powdered material would be spread into layers and then fused using a high intensity beam of light such as a laser. He suggested that plastics or metals could be printed using this technique to create solid objects. This idea led to the creation of Selective Laser Sintering (SLS) which is now widely used in situations that require a high level of accuracy and complicated geometries. [9, 10, 21, 29].

1981 Hideo Kodama (Japan):-

Hideo Kodama was a researcher in Japan who developed one of the first 3D printing systems in 1981. He used photopolymers which harden when exposed to UV light to print 3D objects. This was one of the first examples of 3D printing being used and an essential step towards creating additive manufacturing technologies today. [9, 10, 15, 21].

1984 Chuck Hull:-

In 1984 Chuck Hull developed Stereolithography (SLA). This was the first commercial 3D printing process. It works by using UV light to harden liquid resin in layers to create 3D objects. This was an important advancement for 3D printing as it transformed it from an idea into something usable. This has changed the way manufacturers, designers and engineers make prototypes and products. [9, 10, 15]

1989 S. Scott Crump:-

S. Scott Crump along with his wife Lisa Crump developed a new technique in 1989 called Fused Deposition Modelling (FDM). This uses molten plastic which is then extruded and allowed to cool and solidify. They also co-founded Stratasys which became one of the leading companies in the field. FDM is one of the most widely used techniques for rapid prototyping and low volume manufacturing. [9, 10, 15, 21].

1990s Emanuel “Ely” Sachs:-

In the 1990s Emanuel “Ely” Sachs an engineer at MIT developed Binder Jet Printing. This uses a liquid binder to fuse together powder particles to create a solid object. This increased the range of materials that could be printed. Sachs is also known for creating the name 3D printing which is now used globally.

2000s:-

3D printing expanded to cover more industries such as automotive and aerospace. Most of these were for rapid prototyping. This meant companies could create prototypes quickly reducing costs.

A large breakthrough occurred in 2005 when the RepRap Project was created. This created the first open source 3D printer that could self-replicate. This opened up 3D printing to a larger audience such as researchers, hobbyists and teachers. They could experiment with the technology at a greatly reduced price. [9, 10, 15]

2010s:-

3D printing was used more in the healthcare sector in the 2010s. This included printing prosthetic limbs, dental devices and surgical tools. Being able to create bespoke medical items was a big step forward. In 2015 the FDA approved Spritam an epilepsy drug to be the first 3D printed drug. This was a big achievement in the industry showing that drugs could be personalised to the patient. [9, 15, 21].

2020s:-

The most advanced applications of 3D printing have been seen in the 2020s. This includes developments in personalised medicine. Patients can now have very complex drug delivery systems to meet their needs. For example, tablets can be printed to deliver their drug at specific times or amounts to meet their conditions. Bioprinting has also become an area of interest. This involves printing real tissues and organs. Scientists are investigating if they can print working tissues or organs from humans to transplant or test drugs.

There is also ongoing work to print drugs on demand in hospitals or pharmacies. This could improve the efficiency and personalisation of patient care by providing the perfect dosage and formulation for each individual patient. [1, 9, 15].

HISTORY OF 3D PRINTING IN INDIA:-

3D printing started in the early 2000s in India. It was mainly used for research and models in the IITs and CSIR labs. However, industries such as automobile, aerospace and healthcare have started to use 3D printing to speed up and reduce costs in designing items. In around 2010 companies in India have started to bring 3D printing to the market such as Imaginarium and Objectify. In 2017 doctors at AIIMS performed the first 3D printed spinal implant surgery in India. The government are supporting 3D printing through the “Make in India” programme and the National Strategy for Additive Manufacturing (2022). 3D printing is now used in India to create houses, medical devices and defence components showing good progress in advanced manufacturing. [9, 10, 15, 21]

TYPES OF PHARMACEUTICAL 3D PRINTING SYSTEM:-

3D printing was first developed by Charles Hull in 1986 but has now evolved into various different types. ‘3D printing’ is now an umbrella term for various different technologies that all work by building objects in layers. Most techniques follow a similar process called the ‘3Ds of 3D printing’. Overall there are 6 types of 3D printing that are commonly used in the pharmaceutical industry. These are described below. [9,15,21].

1. Binder Jet Printing Schematic:

figure

Working:-

1. A nozzle with a binder solution is accurately moved across a flat bed of powder in the x- y direction. The binder is deposited only onto the desired regions of powder according to the design of the object. At these points the binder causes the powder particles to adhere together and therefore start to form a solid structure, this will form the first layer of the object. The platform then falls down a little in the z direction so that the next layer can be printed. A roller or similar is used to add a new even layer of powder.

2. The nozzle is then moved across the new layer of powder and binder is deposited into the design required. This is repeated and each layer is built upon the previous layer.

3. After multiple layers have been printed a complete 3D object will be formed, such as a tablet/capsule.This technique allows precise formation of 3D printed medicines/printlets and therefore has huge potential to produce patients specific medications. [9,15,21]

Advantages:

  • Can produce extended release and constant release (zero order) medications.
  • Used to produce the first 3D printed medication to be approved by the US FDA.
  • Can produce immediate release and extended release medications.
  • High resolution means that complex shapes and designs can be produced.

Disadvantages:

  • Expensive.
  • No miniature portable printers.

2. Fused Deposition Modelling (FDM) Schematic:

figure

Working:-

1. In this there is a plastic filament which contains the API that is drug and it fed through a heated nozzle.

2. The plastic is melted and the nozzle moves back and forth to print the liquid onto the flat platform.

3. The platform slowly lowers so that more layers can be printed one by one to form the 3D printed medication. [9,15,21]

Advantages:-

  • Can produce quick acting and slow acting medications.
  • Improves the performance of poorly soluble drugs.
  • Can use multiple nozzles to print.
  • Low cost equipment.
  • Compact, portable and easy to use.

Disadvantages:

  • Not suitable for heat sensitive drugs.
  • Difficult to produce the initial drug filled filament.
  • Not easy to produce on a large scale.
  • May have limitations in drug loading. [9,15,21].

4. Semi-Solid Extrusion Schematic:

figure

Working:-

1. The drug is forced out from a syringe in a thick paste or the gel like Consistency .

2. The head of the printer moves in various/ Multiple directions (i.e left/right, back/front, upward/backward in every direction.

3. This places the drug onto a surface and it solidifies as it cools. [9,15,21]

Advantages:

  • Ideal for chewable and tasty medications.
  • Can produce a variety of products including quick acting, slow releasing, polypills and oral films. [9,15,21]

Disadvantages:

  • Less detail and precision than other 3D printing methods.
  • Only suitable for drugs that can be made into a semi-solid

5.Direct Powder Extrusion:-

figure

Working:

1. The drug powder along with other ingredients are put into a hopper.

2. The powder is then transported by a rotating screw to an area in the printer where it is heated and melts to form a thick liquid. This is then printed and hardened as it cools to form the object.

3. The platform lowers step by step to build up the 3D medication. [9,15,21].

Advantages:

  • Can produce quick acting and slow release medications.
  • Improves poorly soluble drugs by making them more soluble.
  • Suitable for large scale production. For example, Triastek have gained FDA approval to trial a medication produced using this method. [9,15,21]

Disadvantages:

  • Not suitable for heat sensitive drugs.
  • Still a new technology in pharmacy.

6.StereolithographySchematic:

figure

Working:-

1. A liquid resin is cured in thin layers.

2. The resin hardens when exposed to intense light, such as UV light.

3. Once the layer has formed the platform lowers and another layer of resin is added. This continues until the full 3D medication has formed. [9,15,21].

Advantages:

  • Commonly used to produce slow release medications and medical devices.
  • Very precise and can produce intricate shapes, more than other 3D printing methods.
  • Improves the solubility of some drugs in the body.
  • Can be used to produce polypills with multiple layers.

Disadvantages:

  • Not suitable for light sensitive drugs.
  • Some materials may be harmful/toxic. [21]

7.Selective Laser Sintering (SLS) Schematic:

figure

Working :

1. Using a laser the design is traced onto the bed of powder to produce the object, such as a medication.

2. The laser heats specific areas to cause the powder particles to stick together.

3. Another layer of powder is added and this is repeated until the object is complete. [21,29]

Advantages:

  • Can produce fast dissolving medications.
  • Can be designed to have quick acting or slow release.
  • Can produce very intricate shapes, even very small medical instruments.

Disadvantages:

  • Not ideal for light degrading drugs as the laser is used.
  • Powder needs to be very fluid or printing won’t be of good quality.
  • Requires cleaning and finishing.

APPLICATION:-

1.Tablets:-

  • Tablets are the most common type of medication as they are simple to administer, transport and store. Using 3D printing (3DP) it is possible to create individual tablets. [1, 9, 15]
  • Single drug tablets
  • Fast acting tablets: The first tablets created using 3DP were fast acting. Often using FDM as it is simple and suitable for printing tablets.
  • High dose tablets: Tablets with a high dose of drug such as 80% paracetamol can be created. This tablet is mainly used for the slow release tablets, so the drug is released slowly over 24 hrs.
  • Useful for vaccines, insulin and other large molecules that are difficult to absorb. They are more effective than traditional patches and no injections are required. [21]

2.3DP benefits:-

  • Microneedles used to be simple shapes but with 3DP needles can be made to be more pointed, detailed and personalised. They can be more efficient. [21]

Examples:-

1. Vaccines: 3DP was used with hydrogels to create very pointed needles. This helped with pain free vaccine delivery. (Ochoa et al.)

2. Fast printing: A technique called CLIP was used to create very small needles in just 10 minutes. No moulds were needed. (Johnson et al.)

3. Skin cancer: Microneedles were used to deliver chemotherapy drugs slowly over 5 weeks. (Lu et al.)

4. Biodegradable & safe for skin: 3DP needles dissolved into the skin. Drug was released smoothly. (Luzuriaga et al.)

5. Insulin: Special shaped needles delivered insulin in 30 minutes. (Pere et al.)

6. Splint: 3DP patch was used as a small splint. It also delivered pain relief drugs to the trigger finger. (Lim et al.) [21]

Why they are useful:-

  • No pain or fear of needles.
  • Good for large/sensitive drugs (proteins).
  • Fast and controlled drug release.
  • Personalised.
  • Safe and biodegradable.
  • 3DP microneedles are a new way of taking drugs. As they are small, intelligent and gentle they are useful for individuals who don’t like needles. They are mainly useful in the delivering insulin, vaccines & cancer therapies as they are very fast and comfortable.

3.Biorobotics:-

  • Biorobots are small robots which mimic living organisms.
  • They are created using flexible materials and living cells such as heart or muscle cells.
  • The living cells allow them to move. Unlike traditional robots they can twist, move, swim and react to stimuli around them like mini living organisms. [21]

Examples:

Some robots use heart cells. These cause the robot to move or cause the liquid to move.

The flagellum swimmer uses heart cells to create a long tail to enable it to move like a small fish.

Small heart pumps have been created by placing heart cells onto a soft flexible material. The heart cells cause the fluid to move along small tubes. [21]

Special features:

  • They create their own power using living cells.
  • They can be used to deliver medicine or help repair tissue.
  • They can also be used to study small organisms.
  • Scientists have improved them by:
  • Creating patterns in the cells to improve strength.
  • Using electrical or light stimulation to control the robot.
  • Using 3D bioprinting to create bespoke robots for medical purposes. [21]

4. 3D printed models.

  • Helping doctors and easy learning
  • Medical phantoms are life-like models of parts of the body. They are created using 3D printing. Doctors and students can use them to: [21]
  • Plan operations
  • To see the real shape of the organs
  • Practicing medical techniques.
  • Learning about health issues.

Benefits:

  • They are created using real scans such as CT or MRI scans.
  • They provide detailed information such as tumours and blood vessels.
  • Enable doctors to practice.
  • Reduces the chance of making mistakes.

Real life examples:

  • Heart models can be used to study heart defects in babies. They can be touched by doctors and students to understand how it works.
  • Brain models (Alzheimer’s) can be used to show how the Alzheimer’s affects the brain. This helps students and family members understand the illness.
  • Liver models can be used to plan liver operations. They show coloured blood vessels and tumours. They cost under 12,000. ₹
  • Kidney models (for children) can be used by doctors to practice operating on delicate small organs.
  • The cancer or tumors models they show where tl tumour is located within organs (such as liver, kidney) This helps in ensure safe and accurate operation.[21]

5.Overall benefits:

  • Safer operations.
  • Fewer mistakes.
  • Helpful for learning.
  • Cheap (under 8,000). ₹
  • Specifically designed for each patient.

CONCLUSION:-

3D printing has the potential to change the way medicines are produced and used in hospitals and pharmacies. Instead of creating large amounts of medicine, the technology allows small amounts of personalised medicine to be created when needed. This means patients receive safer, more effective personalised medicine. [1, 9, 15]. Pharmacists, doctors and nurses play an important role in implementing this technology. They can help researchers and companies create better healthcare solutions for the future. [9, 10, 15, 21]

REFERENCES

  1. Alomari M, Mohamed FH, Basit AW, et al. Personalised dosing: Printing a dose of one’s own medicine. International Journal of Pharmaceutics. 2015;494:568–77. doi:10.1016/j.ijpharm.2014.12.006
  2. Improving Outcomes Through Personalised Medicine. NHS England. 2016. https://www.england.nhs.uk/wp-content/uploads/2016/09/improving-outcomespersonalised-medicine.pdf (accessed Mar 2022).
  3. The Lancet. Personalised medicine in the UK. The Lancet. 2018;391:e1. doi:10.1016/s0140-6736 (17)33261-0
  4. Sankar PL, Parker LS. The Precision Medicine Initiative’s All of Us Research Program: an agenda for research on its ethical, legal, and social issues. Genetics in Medicine. 2017;19:743–50. doi:10.1038/gim.2016.183
  5. Genome UK: The future of healthcare. Gov.uk. 2020. https://www.gov.uk/government/publications/genome-uk-the-future-of-healthcare/ genomeuk-the-future-of-healthcare (accessed Mar 2022).
  6. Life Sciences Vision (HTML). Gov.uk. 2021. https://www.gov.uk/government/publications/life-sciences-vision/life-sciences-visionhtml (accessed Mar 2022).
  7. Florence AT, Lee VHL. Personalised medicines: More tailored drugs, more tailored delivery. International Journal of Pharmaceutics. 2011;415:29–33. doi:10.1016/j.ijpharm.2011.04.047
  8. Wilsdon T, Edwards G, Lawlor R. The benefits of personalised medicine to patients, society and healthcare systems. EBE Biopharma. 2018. https://www.ebe-biopharma.eu/wp-content/uploads/2018/07/CRA-EBE-EFPIABenefits-of-PM-FinalReport-6-July-2018-STC.pdf (accessed May 2021).
  9. Awad A, Trenfield SJ, Gaisford S, et al. 3D printed medicines: A new branch of digital healthcare. International Journal of Pharmaceutics. 2018;548:586–96. doi:10.1016/j.ijpharm.2018.07.024
  10. Awad A, Trenfield SJ, Goyanes A, et al. Reshaping drug development using 3D printing. Drug Discovery Today. 2018;23:1547–55. doi:10.1016/j.drudis.2018.05.025
  11. Goyanes A, Scarpa M, Kamlow M, et al. Patient acceptability of 3D printed medicines. International Journal of Pharmaceutics. 2017;530:71–8. doi:10.1016/j.ijpharm.2017.07.064
  12. Trenfield SJ, Goyanes A, Gaisford S, et al. Editorial: Innovations in 2D and 3D printed pharmaceuticals. International Journal of Pharmaceutics. 2021;605:120839. doi:10.1016/j.ijpharm.2021.120839
  13. Goyanes A, Fina F, Martorana A, et al. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. International Journal of Pharmaceutics. 2017;527:21–30. doi:10.1016/j.ijpharm.2017.05.021
  14. Hamburg MA, Collins FS. The Path to Personalized Medicine. N Engl J Med. 2010;363:301–4. doi:10.1056/nejmp1006304
  15. Trenfield SJ, Awad A, Goyanes A, et al. 3D Printing Pharmaceuticals: Drug Development to Frontline Care. Trends in Pharmacological Sciences. 2018;39:440–51. doi:10.1016/j.tips.2018.02.006
  16. Öblom H, Zhang J, Pimparade M, et al. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release. AAPS PharmSciTech. 2019;20. doi:10.1208/s12249-018-1233-7
  17. Gioumouxouzis CI, Tzimtzimis E, Katsamenis OL, et al. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients. European Journal of Pharmaceutical Sciences. 2020;143:105176. doi:10.1016/j.ejps.2019.105176
  18. Reddy Dumpa N, Bandari S, A. Repka M. Novel Gastroretentive Floating Pulsatile Drug Delivery System Produced via Hot-Melt Extrusion and Fused Deposition Modeling 3D Printing. Pharmaceutics. 2020;12:52. doi:10.3390/pharmaceutics12010052
  19. Chatzitaki A-T, Tsongas K, Tzimtzimis EK, et al. 3D printing of patient-tailored SNEDDS-based suppositories of lidocaine. Journal of Drug Delivery Science and Technology. 2021;61:102292. doi:10.1016/j.jddst.2020.102292
  20. Krause J, Müller L, Sarwinska D, et al. 3D Printing of Mini Tablets for Pediatric Use. Pharmaceuticals. 2021;14:143. doi:10.3390/ph14020143
  21. Wang J, Zhang Y, Aghda NH, et al. Emerging 3D printing technologies for drug delivery devices: Current status and future perspective. Advanced Drug Delivery Reviews. 2021;174:294–316. doi:10.1016/j.addr.2021.04.019
  22. Khaled SA, Burley JC, Alexander MR, et al. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. Journal of Controlled Release. 2015;217:308–14. doi:10.1016/j.jconrel.2015.09.028
  23. Khaled SA, Burley JC, Alexander MR, et al. 3D printing of tablets containing multiple drugs with defined release profiles. International Journal of Pharmaceutics. 2015;494:643–50. doi:10.1016/j.ijpharm.2015.07.067
  24. Sadia M, Isreb A, Abbadi I, et al. From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets. European Journal of Pharmaceutical Sciences. 2018;123:484–94. doi:10.1016/j.ejps.2018.07.045
  25. Genina N, Boetker JP, Colombo S, et al. Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing. Journal of Controlled Release. 2017;268:40–8. doi:10.1016/j.jconrel.2017.10.003
  26. Robles-Martinez P, Xu X, Trenfield SJ, et al. 3D Printing of a Multi-Layered Polypill Containing Six Drugs Using a Novel Stereolithographic Method. Pharmaceutics. 2019;11:274. doi:10.3390/pharmaceutics11060274
  27. Gioumouxouzis CI, Baklavaridis A, Katsamenis OL, et al. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery. European Journal of Pharmaceutical Sciences. 2018;120:40–52. doi:10.1016/j.ejps.2018.04.020
  28. Seoane-Viaño I, Ong JJ, Luzardo-Álvarez A, et al. 3D printed tacrolimus suppositories for the treatment of ulcerative colitis. Asian Journal of Pharmaceutical Sciences. 2021;16:110–9. doi:10.1016/j.ajps.2020.06.003
  29. Yang Y, Xu Y, Wei S, et al. Oral preparations with tunable dissolution behavior based on selective laser sintering technique. International Journal of Pharmaceutics. 2021;593:120127. doi:10.1016/j.ijpharm.2020.120127

Reference

  1. Alomari M, Mohamed FH, Basit AW, et al. Personalised dosing: Printing a dose of one’s own medicine. International Journal of Pharmaceutics. 2015;494:568–77. doi:10.1016/j.ijpharm.2014.12.006
  2. Improving Outcomes Through Personalised Medicine. NHS England. 2016. https://www.england.nhs.uk/wp-content/uploads/2016/09/improving-outcomespersonalised-medicine.pdf (accessed Mar 2022).
  3. The Lancet. Personalised medicine in the UK. The Lancet. 2018;391:e1. doi:10.1016/s0140-6736 (17)33261-0
  4. Sankar PL, Parker LS. The Precision Medicine Initiative’s All of Us Research Program: an agenda for research on its ethical, legal, and social issues. Genetics in Medicine. 2017;19:743–50. doi:10.1038/gim.2016.183
  5. Genome UK: The future of healthcare. Gov.uk. 2020. https://www.gov.uk/government/publications/genome-uk-the-future-of-healthcare/ genomeuk-the-future-of-healthcare (accessed Mar 2022).
  6. Life Sciences Vision (HTML). Gov.uk. 2021. https://www.gov.uk/government/publications/life-sciences-vision/life-sciences-visionhtml (accessed Mar 2022).
  7. Florence AT, Lee VHL. Personalised medicines: More tailored drugs, more tailored delivery. International Journal of Pharmaceutics. 2011;415:29–33. doi:10.1016/j.ijpharm.2011.04.047
  8. Wilsdon T, Edwards G, Lawlor R. The benefits of personalised medicine to patients, society and healthcare systems. EBE Biopharma. 2018. https://www.ebe-biopharma.eu/wp-content/uploads/2018/07/CRA-EBE-EFPIABenefits-of-PM-FinalReport-6-July-2018-STC.pdf (accessed May 2021).
  9. Awad A, Trenfield SJ, Gaisford S, et al. 3D printed medicines: A new branch of digital healthcare. International Journal of Pharmaceutics. 2018;548:586–96. doi:10.1016/j.ijpharm.2018.07.024
  10. Awad A, Trenfield SJ, Goyanes A, et al. Reshaping drug development using 3D printing. Drug Discovery Today. 2018;23:1547–55. doi:10.1016/j.drudis.2018.05.025
  11. Goyanes A, Scarpa M, Kamlow M, et al. Patient acceptability of 3D printed medicines. International Journal of Pharmaceutics. 2017;530:71–8. doi:10.1016/j.ijpharm.2017.07.064
  12. Trenfield SJ, Goyanes A, Gaisford S, et al. Editorial: Innovations in 2D and 3D printed pharmaceuticals. International Journal of Pharmaceutics. 2021;605:120839. doi:10.1016/j.ijpharm.2021.120839
  13. Goyanes A, Fina F, Martorana A, et al. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. International Journal of Pharmaceutics. 2017;527:21–30. doi:10.1016/j.ijpharm.2017.05.021
  14. Hamburg MA, Collins FS. The Path to Personalized Medicine. N Engl J Med. 2010;363:301–4. doi:10.1056/nejmp1006304
  15. Trenfield SJ, Awad A, Goyanes A, et al. 3D Printing Pharmaceuticals: Drug Development to Frontline Care. Trends in Pharmacological Sciences. 2018;39:440–51. doi:10.1016/j.tips.2018.02.006
  16. Öblom H, Zhang J, Pimparade M, et al. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release. AAPS PharmSciTech. 2019;20. doi:10.1208/s12249-018-1233-7
  17. Gioumouxouzis CI, Tzimtzimis E, Katsamenis OL, et al. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients. European Journal of Pharmaceutical Sciences. 2020;143:105176. doi:10.1016/j.ejps.2019.105176
  18. Reddy Dumpa N, Bandari S, A. Repka M. Novel Gastroretentive Floating Pulsatile Drug Delivery System Produced via Hot-Melt Extrusion and Fused Deposition Modeling 3D Printing. Pharmaceutics. 2020;12:52. doi:10.3390/pharmaceutics12010052
  19. Chatzitaki A-T, Tsongas K, Tzimtzimis EK, et al. 3D printing of patient-tailored SNEDDS-based suppositories of lidocaine. Journal of Drug Delivery Science and Technology. 2021;61:102292. doi:10.1016/j.jddst.2020.102292
  20. Krause J, Müller L, Sarwinska D, et al. 3D Printing of Mini Tablets for Pediatric Use. Pharmaceuticals. 2021;14:143. doi:10.3390/ph14020143
  21. Wang J, Zhang Y, Aghda NH, et al. Emerging 3D printing technologies for drug delivery devices: Current status and future perspective. Advanced Drug Delivery Reviews. 2021;174:294–316. doi:10.1016/j.addr.2021.04.019
  22. Khaled SA, Burley JC, Alexander MR, et al. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. Journal of Controlled Release. 2015;217:308–14. doi:10.1016/j.jconrel.2015.09.028
  23. Khaled SA, Burley JC, Alexander MR, et al. 3D printing of tablets containing multiple drugs with defined release profiles. International Journal of Pharmaceutics. 2015;494:643–50. doi:10.1016/j.ijpharm.2015.07.067
  24. Sadia M, Isreb A, Abbadi I, et al. From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets. European Journal of Pharmaceutical Sciences. 2018;123:484–94. doi:10.1016/j.ejps.2018.07.045
  25. Genina N, Boetker JP, Colombo S, et al. Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing. Journal of Controlled Release. 2017;268:40–8. doi:10.1016/j.jconrel.2017.10.003
  26. Robles-Martinez P, Xu X, Trenfield SJ, et al. 3D Printing of a Multi-Layered Polypill Containing Six Drugs Using a Novel Stereolithographic Method. Pharmaceutics. 2019;11:274. doi:10.3390/pharmaceutics11060274
  27. Gioumouxouzis CI, Baklavaridis A, Katsamenis OL, et al. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery. European Journal of Pharmaceutical Sciences. 2018;120:40–52. doi:10.1016/j.ejps.2018.04.020
  28. Seoane-Viaño I, Ong JJ, Luzardo-Álvarez A, et al. 3D printed tacrolimus suppositories for the treatment of ulcerative colitis. Asian Journal of Pharmaceutical Sciences. 2021;16:110–9. doi:10.1016/j.ajps.2020.06.003
  29. Yang Y, Xu Y, Wei S, et al. Oral preparations with tunable dissolution behavior based on selective laser sintering technique. International Journal of Pharmaceutics. 2021;593:120127. doi:10.1016/j.ijpharm.2020.120127

Photo
Prachi Ghadage
Corresponding author

M Pharm & Professor, Pharmacy Department, Shahajirao Patil Vikas Pratishthan’s S.B Patil College of pharmacy

Photo
Trushna Gardale
Co-author

Final Year B Pharmacy Student, Pharmacy Department, Shahajirao Patil Vikas Pratishthan’s S.B Patil College of Pharmacy.

Photo
Neha Ghule
Co-author

Final Year B Pharmacy Student, Pharmacy Department, Shahajirao Patil Vikas Pratishthan’s S.B Patil College of Pharmacy.

Trushna Gardade, Neha Ghule, Prachi Ghadage, Dose by Design: Pharmacy in 3-Dimensional Printing Era, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 11, 2720-2730. https://doi.org/10.5281/zenodo.24308422

More related articles
A Comprehensive Review on Efficacy, Safety, and Gl...
Krishna Kamal Mishra, Sujeet Pratap Singh, Pramod Kumar Mishra, D...
Management of Diabetes-Associated Cognitive Impair...
Dr. M. Sreekanth, Syeda Sumaiya, Nomula Pavani...
Natural Deep Eutectic Solvent-Based Enhancement of...
Dr. Hardik Koli, Harshada Sutar, Diksha Kognole, Dhananjay Narke,...
Related Articles
A Comprehensive Review of Hyphenated Techniques in Pharmaceutical Analysis:Basic...
Polaki Reshma, Varri Srinivasarao, Pappula Niranjani, Mutyala Vasantha, Maddi Ramaiah, Kotyada Sunit...
Article on Chromatography and Overview of HPLC Instrumentation...
Sudarsanam Nagarjuna, Shaik Naziya, Manchala Beula, Leishangthem Dibiya Devi, Kopalle Sravani, Kondu...
Formulation and Evaluation of BODY WASH USING Psidium Guajava, Hibiscus Rosa-Sin...
Usman Afeeja, Athira Krishnan, Arya Chullikkal, Varun. K., Swetha. S., Asif. N., Dr. Sreekanth Kaith...
A Comprehensive Review on Efficacy, Safety, and Global Integration of Alternativ...
Krishna Kamal Mishra, Sujeet Pratap Singh, Pramod Kumar Mishra, Dr. Tarkeshwar Prasad Shukla...
More related articles
A Comprehensive Review on Efficacy, Safety, and Global Integration of Alternativ...
Krishna Kamal Mishra, Sujeet Pratap Singh, Pramod Kumar Mishra, Dr. Tarkeshwar Prasad Shukla...
Natural Deep Eutectic Solvent-Based Enhancement of Naproxen Solubility for Oral ...
Dr. Hardik Koli, Harshada Sutar, Diksha Kognole, Dhananjay Narke, Gayatri Patil, Deeksha Kodole, Dr....
A Comprehensive Review on Efficacy, Safety, and Global Integration of Alternativ...
Krishna Kamal Mishra, Sujeet Pratap Singh, Pramod Kumar Mishra, Dr. Tarkeshwar Prasad Shukla...
Natural Deep Eutectic Solvent-Based Enhancement of Naproxen Solubility for Oral ...
Dr. Hardik Koli, Harshada Sutar, Diksha Kognole, Dhananjay Narke, Gayatri Patil, Deeksha Kodole, Dr....